Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

Rani Therapeutics Holdings Inc. (NASDAQ:RANI) is one of the hot stocks to buy with huge upside potential. On October 21, H.C.

Rani Therapeutics stock surged 200% after securing a $1 billion partnership with Chugai and raising $60 million in funding.

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the ...

Shares of Rani Therapeutics Holdings have doubled, to $1.12, in premarket trading after the company said it has entered into a collaboration and license agreement with Chugai Pharmaceutical.

In a thrilling #AskSRK event, fans buzzed with anticipation for Shah Rukh Khan's forthcoming project, 'King'. When one ...